Você está na página 1de 1

 Upadhyay J, Rao R. Assessment of the causality of drug induced cutaneous manifestations.

MRIMS Journal of Health Sciences 2015; 3(196-199) (cited 2018 July 5th).
 Bliss A, Warnock J. Psychiatric medications: Adverse cutaneous drug reactions. Clinics
in Dermatology 2013; 31(101–109). (Cited 2018 July 5th).
 Stern R. Exanthematous Drug Eruptions. The New England Journal of Medicine 2012;
366(2492-2501). (Cited 2018 july 5th).
 Alomar M. Factors affecting the development of adverse drug reactions (Review article).
Saudi Pharmaceutical Journal 2014; 22(83-94). (Cited 2018 July 5th).
 Kluwer W. Maculopapular Drug Eruption versus MaculopapularViral Exanthem. Indian
Journal of Drugs in Dermatology 2017; 3(45-47). (Cited 2018 July 5th).
 Vora R, Rochit S, Trusha P, Khushboo M. A Study of Adverse Cutaneous Drug Reactions
Due to Nsaids at a Rural Based Tertiary Care Centre, Gujarat. International Journal of
Pharmacovigilance 2018; 3(1-4). (Cited 2018 July 5th).
 Kowalski M, Makowska J. Seven Steps to the Diagnosis of NSAIDs Hypersensitivity: How
toApply a New Classification in Real Practice? Allergy Asthma Immunology Research
2015; 7(312-320). (Cited 2018 July 5th).
 Fernández-Jorge B, Goday JJ, Almagro M, Fonseca E. Fixed Drug Eruption Due to
Piroxicam. Actas Dermosifiliog 2008; 99(239-240) (cited 2018 July 5th).
 Khan D. Cutaneous drug reactions. American Academy of Allergy, Asthma &
Immunology 2012; 130(1225-1225e6) (Cited 2018 July 5th).

Você também pode gostar